New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite ...

Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.

Attendees might be looking to wean off weight-loss drugs or mitigate side effects such as digestive discomfort and muscle ...

Former world No 1s Naomi Osaka and Victoria Azarenka both advanced to the second round in the Wimbledon warm-up tournament at ...

India and England will renew their rivalry and lock horns in the first Test of the five-match series in Leeds from June 20 to ...

GLP-1 medications such as Wegovy, Mounjaro and Ozempic helped drive a 9% year-over-year increase in U.S. prescription dispensing revenue, which reached $683 billion in 2024.  A separate report found ...

In a Cleveland Clinic cohort, patients who stopped treatment for obesity had smaller weight losses to start, making these ...

It was 96 degrees in the air and much, much hotter on track at Road America as Alex Palou won the XPEL Grand Prix during an ...